title: [Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias].
abstract: The effect of Beta-Sitosterol (Sitosterin Delalande) on plasma lipids in 20 pretreated patients with type IIa and IIb familial hyperlipoproteinemia is reported. 6-18 g of the drug were given for a time of two to twelve months. In 11 patients the plasma cholesterol level decreased between 10 and 30%. Since Beta-Sitosterol has no effect on plasma triglycerides, an additional hypertriglyceridemia must be taken care of and treated if necessary. Beta-Sitosterol can be called an effective substance in the treatment of hypercholesterinemia. In addition the diet cure becomes easier.
mesh_terms: D000328:Adult; D000368:Aged; D002791:Cholesterol, Dietary; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012855:Sitosterols / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D002791:Cholesterol, Dietary; D012855:Sitosterols; D014280:Triglycerides
vernacular_title: Beta-Sitosterin in der Behandlung essentieller Hyperlipoproteinämien vom Typ II.